-
Je něco špatně v tomto záznamu ?
Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients
M. Švajdler, R. Mezencev, J. Kašpírková, D. Kacerovská, DV. Kazakov, O. Ondič, M. Michal,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- biopsie MeSH
- Bowenova nemoc chemie imunologie virologie MeSH
- DNA testy na papilomavirus MeSH
- DNA virů genetika MeSH
- imunohistochemie MeSH
- imunokompromitovaný pacient * MeSH
- infekce papilomavirem imunologie virologie MeSH
- inhibitor p16 cyklin-dependentní kinasy analýza MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery analýza MeSH
- nádory kůže chemie imunologie virologie MeSH
- Papillomaviridae genetika imunologie patogenita MeSH
- pilotní projekty MeSH
- prediktivní hodnota testů MeSH
- prekancerózy chemie imunologie virologie MeSH
- průřezové studie MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- virová transformace buněk MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
An increased rate of second nonmelanoma skin cancers is found in immunocompromised patients. Epidemiological and molecular data implicate ultraviolet radiation as the major risk factor. In addition, there is increasing evidence supporting the role of human papillomavirus (HPV) in the pathogenesis of premalignant and malignant skin lesions in both immunocompetent and immunocompromised patients. In a retrospective cross-sectional study, the authors examined the expression of p16 by immunohistochemistry and the presence of mucosal (α-genus) and cutaneous/epidermodysplasia verruciformis (β-genus) HPV DNA by polymerase chain reaction in 29 biopsy specimens of extragenital/extraungual Bowen disease (BD) from 24 Eastern European white immunocompromised patients. Furthermore, the author evaluated the association between the expression of p16 protein and the presence of HPV DNA. Among 25 specimens from 21 patients evaluable by polymerase chain reaction, HPV DNA was detected in 10 (40%) BD lesions from 9 patients. Beta-HPV predominated over alpha-HPV types. Among 29 immunohistochemically evaluable BD specimens, 22 lesions (∼76%) from 20 patients were scored as p16 positive. HPV DNA-positive and HPV DNA-negative lesions displayed the same proportion of p16 positivity (80%) and no correlation was found between the HPV DNA presence and the p16 expression status. Our pilot study demonstrated that β-HPV infections predominate in BD cases diagnosed among immunocompromised patients, although high- and low-risk mucosal (alpha) HPV genotypes may be detected in a minority of cases. In contrast to anogenital HPV-associated lesions, positive p16 expression is not a reliable marker of high-risk α-HPV infection in BD cases, as it can be also detected in β-HPV infected and HPV-negative cases.
†Bioptická laboratoř s r o Pilsen Czech Republic
‡Department of Pathology Louis Pasteur University Hospital Košice Slovakia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014083
- 003
- CZ-PrNML
- 005
- 20200720081013.0
- 007
- ta
- 008
- 170413s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/DAD.0000000000000530 $2 doi
- 035 __
- $a (PubMed)26913849
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Švajdler, Marián $u *Šikl's Department of Pathology, the Faculty of Medicine and Faculty Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic; †Bioptická laboratoř, s.r.o., Pilsen, Czech Republic; ‡Department of Pathology, Louis Pasteur University Hospital, Košice, Slovakia; and §Integrated Cancer Research Center, School of Biology and Parker H. Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA.
- 245 10
- $a Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients / $c M. Švajdler, R. Mezencev, J. Kašpírková, D. Kacerovská, DV. Kazakov, O. Ondič, M. Michal,
- 520 9_
- $a An increased rate of second nonmelanoma skin cancers is found in immunocompromised patients. Epidemiological and molecular data implicate ultraviolet radiation as the major risk factor. In addition, there is increasing evidence supporting the role of human papillomavirus (HPV) in the pathogenesis of premalignant and malignant skin lesions in both immunocompetent and immunocompromised patients. In a retrospective cross-sectional study, the authors examined the expression of p16 by immunohistochemistry and the presence of mucosal (α-genus) and cutaneous/epidermodysplasia verruciformis (β-genus) HPV DNA by polymerase chain reaction in 29 biopsy specimens of extragenital/extraungual Bowen disease (BD) from 24 Eastern European white immunocompromised patients. Furthermore, the author evaluated the association between the expression of p16 protein and the presence of HPV DNA. Among 25 specimens from 21 patients evaluable by polymerase chain reaction, HPV DNA was detected in 10 (40%) BD lesions from 9 patients. Beta-HPV predominated over alpha-HPV types. Among 29 immunohistochemically evaluable BD specimens, 22 lesions (∼76%) from 20 patients were scored as p16 positive. HPV DNA-positive and HPV DNA-negative lesions displayed the same proportion of p16 positivity (80%) and no correlation was found between the HPV DNA presence and the p16 expression status. Our pilot study demonstrated that β-HPV infections predominate in BD cases diagnosed among immunocompromised patients, although high- and low-risk mucosal (alpha) HPV genotypes may be detected in a minority of cases. In contrast to anogenital HPV-associated lesions, positive p16 expression is not a reliable marker of high-risk α-HPV infection in BD cases, as it can be also detected in β-HPV infected and HPV-negative cases.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádorové biomarkery $x analýza $7 D014408
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a Bowenova nemoc $x chemie $x imunologie $x virologie $7 D001913
- 650 _2
- $a virová transformace buněk $7 D002472
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a inhibitor p16 cyklin-dependentní kinasy $x analýza $7 D019941
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a DNA virů $x genetika $7 D004279
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a DNA testy na papilomavirus $7 D061809
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a imunokompromitovaný pacient $7 D016867
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Papillomaviridae $x genetika $x imunologie $x patogenita $7 D027383
- 650 _2
- $a infekce papilomavirem $x imunologie $x virologie $7 D030361
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a prekancerózy $x chemie $x imunologie $x virologie $7 D011230
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a nádory kůže $x chemie $x imunologie $x virologie $7 D012878
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mezencev, Roman
- 700 1_
- $a Němcová, Jana $7 xx0233246
- 700 1_
- $a Kacerovská, Denisa
- 700 1_
- $a Kazakov, Dmitry V
- 700 1_
- $a Ondič, Ondrej
- 700 1_
- $a Michal, Michal
- 773 0_
- $w MED00000240 $t The American Journal of dermatopathology $x 1533-0311 $g Roč. 38, č. 10 (2016), s. 751-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26913849 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20200720081013 $b ABA008
- 999 __
- $a ok $b bmc $g 1200548 $s 974861
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 38 $c 10 $d 751-7 $i 1533-0311 $m The American journal of dermatopathology $n Am J Dermatopathol $x MED00000240
- LZP __
- $a Pubmed-20170413